Cefuroxime: Difference between revisions
Jump to navigation
Jump to search
New page: <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalos... |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | ||
Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin<ref name="a2">Katzung B (2018). Basic & Clinical Pharmacology. McGraw Hill. p. 803.</ref> antibiotic used to treat and prevent a number of bacterial infections.<ref name="a3">British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 518. ISBN 9780857113382.</ref> These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease.<ref name="a4">[https://www.drugs.com/monograph/cefuroxime.html "Cefuroxime Sodium Monograph for Professionals".] Drugs.com. American Society of Health-System Pharmacists. Retrieved 22 March 2019.</ref> | Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin<ref name="a2">Katzung B (2018). Basic & Clinical Pharmacology. McGraw Hill. p. 803.</ref> antibiotic used to treat and prevent a number of bacterial infections.<ref name="a3">British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 518. ISBN 9780857113382.</ref> These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease.<ref name="a4">[https://www.drugs.com/monograph/cefuroxime.html "Cefuroxime Sodium Monograph for Professionals".] Drugs.com. American Society of Health-System Pharmacists. Retrieved 22 March 2019.</ref> See also [[https://en.wikipedia.org/wiki/Cefuroxime Cefuroxime]]. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 12:43, 15 April 2024
Cefuroxime, sold under the brand name Zinacef among others, is a second-generation cephalosporin[1] antibiotic used to treat and prevent a number of bacterial infections.[2] These include pneumonia, meningitis, otitis media, sepsis, urinary tract infections, and Lyme disease.[3] See also [Cefuroxime].
|
| ||||||||||
ReferencesReferences
- ↑ Katzung B (2018). Basic & Clinical Pharmacology. McGraw Hill. p. 803.
- ↑ British national formulary : BNF 76 (76 ed.). Pharmaceutical Press. 2018. p. 518. ISBN 9780857113382.
- ↑ "Cefuroxime Sodium Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Retrieved 22 March 2019.